News & Events

Press Release

Taiwan Liposome Company to Attend 37th Annual J.P. Morgan Healthcare conference
TAIPEI, Taiwan and SOUTH SAN FRANCISCO, Calif., – January 2, 2019 – Taiwan Liposome Company, Ltd. (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of novel nanomedicines designed to target areas of unmet medical need in pain management, ophthalmology and oncology, today announced that the Company will attend and participate in investor meetings at the 37th Annual J.P. Morgan Healthcare Conference being held from January 7-11 at the Westin St. Francis in San Francisco, CA.